For more than 250 years–and 30 years as Novartis–we’ve pursued scientific breakthroughs for one purpose: people. Today, we take on the toughest challenges in healthcare and turn innovations into medicines that redefine the future for patients.

Novartis Financial Results - Q1 2026

Novartis announces the company’s financial results for the first quarter of 2026.

Learn more

Happy father with daughter on his shoulders under a clear blue sky

Therapeutic areas

Discover our medicines

Close up on the hands of a laboratory technician wearing blue gloves preparing a sample with pipette

Research and development

Explore our science

HCP wearing a medical coat pulling a cart bicycle in rural african village

ESG

Learn about our impact

Two business people smiling in a modern and bright room

Careers

Join our team

Latest news

Apr 28, 2026

Ad hoc release

Novartis delivered strong growth in priority brands and launches in Q1; FY 2026 guidance reaffirmed

Apr 27, 2026

Press release

Novartis Rhapsido® receives European Commission approval as first oral targeted treatment for chronic spontaneous urticaria

Apr 24, 2026

Press release

Novartis receives positive CHMP opinion for Itvisma® for spinal muscular atrophy (SMA)

All news

Scientist in protective gear working in a laboratory

Manufacturing expansion in the United States

Novartis is expanding our manufacturing and R&D facilities in the US to scale innovation, help patients and create jobs.

Learn more

Bringing breakthroughs to more patients

At Novartis, we don’t just discover life-changing medicines, we're part of a broader effort to help ensure medicines reach the people who need them most, wherever they live, because the true value of innovation lies in its ability to improve lives.

Read our full statement